UFC light heavyweight Nick Roehrick has accepted a one-year suspension from the U.S. Anti-Doping Agency. Roehrick was notified last month of a potential UFC anti-doping violation stemming from an August 8th test.
Roehrick tested positive for the presence of clomiphene, an estrogen blocker banned year-round, and its metabolite, 4-hydroxyclomiphene. The suspension is retroactive to August 17, 2017, when the provisional suspension was imposed.
Via the USADA release:
Clomiphene is not approved by the U.S. Food & Drug Administration (FDA) for use in the male population, meaning such off-label clinical use has not been thoroughly studied for safety and efficacy. Clomiphene also indirectly promotes the secretion of testosterone. Increasing testosterone, especially when combined with strength training, has been demonstrated to increase fat-free mass, muscle size, and strength in males, potentially leading to performance enhancement in sport.
Payout Perspective:
The 30-year-old fighter had just one fight in the UFC, a loss to Jarod Cannonier at the TUF 25 Finale in July. The maximum sentence for a first offense is 2 years so the 1 years suspension mitigates a prolonged appeal process.
Leave a Reply